PERTZYE - 59767-008-99 - (pancrelipase)

Alphabetical Index


Drug Information of PERTZYE

Product NDC: 59767-008
Proprietary Name: PERTZYE
Non Proprietary Name: pancrelipase
Active Ingredient(s): 30250; 8000; 28750    [USP'U]/1; [USP'U]/1; [USP'U]/1 & nbsp;   pancrelipase
Administration Route(s): ORAL
Dosage Form(s): CAPSULE, DELAYED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of PERTZYE

Product NDC: 59767-008
Labeler Name: Digestive Care, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA022175
Marketing Category: NDA
Start Marketing Date: 20120517

Package Information of PERTZYE

Package NDC: 59767-008-99
Package Description: 1 BOTTLE in 1 CARTON (59767-008-99) > 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE

NDC Information of PERTZYE

NDC Code 59767-008-99
Proprietary Name PERTZYE
Package Description 1 BOTTLE in 1 CARTON (59767-008-99) > 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE
Product NDC 59767-008
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name pancrelipase
Dosage Form Name CAPSULE, DELAYED RELEASE
Route Name ORAL
Start Marketing Date 20120517
Marketing Category Name NDA
Labeler Name Digestive Care, Inc.
Substance Name PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE
Strength Number 30250; 8000; 28750
Strength Unit [USP'U]/1; [USP'U]/1; [USP'U]/1
Pharmaceutical Classes

Complete Information of PERTZYE


General Information